MHR Fund Management - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
MHR Fund Management ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$90,986,819
+7.7%
19,997,103
+66.7%
11.15%
-6.1%
Q2 2023$84,459,605
+15.2%
11,997,1030.0%11.88%
+20.4%
Q1 2023$73,302,299
-4.4%
11,997,1030.0%9.86%
-24.6%
Q4 2022$76,661,48811,997,10313.08%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders